Prof. Marek Trněný | ICML 2017 | Update on the phase III GOYA study in DLBCL

Anne Villeneuve

Marek Trněný

Jun 22, 2017

Update on the phase III GOYA study in DLBCL

More about...

Aggressive B-cell lymphomas Anne Villeneuve Diffuse large B-cell lymphoma GOYA ICML 2017 Marek Trněný

Educational theme: High-risk patients with lymphoid malignancies

Despite the plethora of regimens and the chemosensitivity of aggressive B-cell lymphomas, many patients fail to respond well to treatment. This article collates expert opinions...

Sep 12, 2019

Educational theme: High-risk patients with lymphoid malignancies

Despite the plethora of regimens and the chemosensitivity of aggressive B-cell lymphomas, many patients fail to respond well to...

Sep 12, 2019

Prof. Marek Trneny | EBMT 2018 | What were the most interesting results from EBMT?

What were the most interesting results from EBMT?

Mar 23, 2018

Prof. Marek Trneny | EBMT 2018 | What were the most interesting results from EBMT?

What were the most interesting results from EBMT?

Mar 23, 2018

Subscribe to get the best content related to lymphoma & CLL delivered to your inbox every month

First Name

Last Name

I agree to the Lymphoma Hub Terms & Conditions

The Lymphoma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Prof. Marek Trněný | ICML 2017 | Update on the phase III GOYA study in DLBCL

Anne Villeneuve

Marek Trněný

Jun 22, 2017

More about...

Related articles

Sep 12, 2019

Sep 12, 2019

Mar 23, 2018

Mar 23, 2018

Newsletter